July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
A Novel GelMA-based Bioadhesive for Repair of Corneal Stromal Defects
Author Affiliations & Notes
  • ZHONGMOU SUN
    Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts, United States
  • Ahmad Kheirkhah
    Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts, United States
  • Rani Al Karmi
    Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts, United States
  • William Foulsham
    Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts, United States
  • Ehsan Shirzaei Sani
    Chemistry Engineering, Northeastern University , Boston, Massachusetts, United States
  • Nasim Annabi
    Chemistry Engineering, Northeastern University , Boston, Massachusetts, United States
  • Reza Dana
    Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   ZHONGMOU SUN, Brigham and Women's Hospital (P), Massachusetts Eye and Ear (P); Ahmad Kheirkhah, Brigham and Women's Hospital (P), Massachusetts Eye and Ear (P); Rani Al Karmi, Brigham and Women's Hospital (P), Massachusetts Eye and Ear (P); William Foulsham, Brigham and Women's Hospital (P), Massachusetts Eye and Ear (P); Ehsan Shirzaei Sani, Brigham and Women's Hospital (P), Massachusetts Eye and Ear (P); Nasim Annabi, Brigham and Women's Hospital (P), Massachusetts Eye and Ear (P); Reza Dana, Brigham and Women's Hospital (P), Massachusetts Eye and Ear (P)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1411. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      ZHONGMOU SUN, Ahmad Kheirkhah, Rani Al Karmi, William Foulsham, Ehsan Shirzaei Sani, Nasim Annabi, Reza Dana; A Novel GelMA-based Bioadhesive for Repair of Corneal Stromal Defects. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1411.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Unlike epithelial defects, corneal stromal defects heal very slowly and can cause permanent vision loss due to fibrosis and scarring. Currently, there is no treatment to replenish the corneal stroma. Gelatin methacryloyl (GelMA) hydrogels, which resemble the extracellular matrix, are biocompatible and widely used in tissue engineering. Here, we engineered a transparent and visible light-crosslinkable GelMA-based bioadhesive and evaluated its physical properties, biocompatibility, as well as retention on the cornea.

Methods : We engineered visible light-crosslinkable GelMA-based bioadhesive, in which the concentrations of GelMA and degree of methacryloyl functionalization are tunable. Physical and adhesive properties of the bioadhesive were characterized in vitro. Cell viability and metabolic activity of human keratocytes encapsulated in GelMA were also determined using Live/Dead and PrestoBlue assays, respectively. Defects with 50% depth were created in the central cornea of isolated New Zealand rabbit eyes, and GelMA adhesive was used to fill and seal the defects. Retention of the bioadhesive was then evaluated using Anterior Segment Optical Coherence Tomography over a 4-week period.

Results : Compared to commercially available adhesives Evicel® and CoSEAL®, GelMA-based adhesive had higher adhesion strength (3.5-fold and 4.6-fold, p<0.001 and p<0.01, respectively), higher shear strength (1.7-fold and 5.1-fold, p<0.01 and p<0.0001, respectively), and higher burst pressure resistance (41.0-fold and 37.7-fold, p<0.0001 and p<0.0001, respectively). We observed more than 90% keratocyte viability and a 10-fold increase in cell metabolic activity after 7 days of cell culture. Our ex vivo data showed that the GelMA-based bioadhesive remained intact and stayed completely attached to the cornea over the 4-week follow up.

Conclusions : This GelMA-based bioadhesive is tunable for optimal physical and adhesive properties. It is nontoxic to keratocytes, has high retention on the cornea, and offers a novel alternative for treatment of stromal defects.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×